Cargando…
COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833354/ https://www.ncbi.nlm.nih.gov/pubmed/32522559 http://dx.doi.org/10.1016/j.cgh.2020.06.002 |
| _version_ | 1783642045640867840 |
|---|---|
| author | Caron, Benedicte Arondel, Yves Reimund, Jean-Marie |
| author_facet | Caron, Benedicte Arondel, Yves Reimund, Jean-Marie |
| author_sort | Caron, Benedicte |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833354 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78333542021-01-26 COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? Caron, Benedicte Arondel, Yves Reimund, Jean-Marie Clin Gastroenterol Hepatol Letter to the Editor by the AGA Institute 2020-10 2020-06-06 /pmc/articles/PMC7833354/ /pubmed/32522559 http://dx.doi.org/10.1016/j.cgh.2020.06.002 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Caron, Benedicte Arondel, Yves Reimund, Jean-Marie COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? |
| title | COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? |
| title_full | COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? |
| title_fullStr | COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? |
| title_full_unstemmed | COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? |
| title_short | COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment? |
| title_sort | covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833354/ https://www.ncbi.nlm.nih.gov/pubmed/32522559 http://dx.doi.org/10.1016/j.cgh.2020.06.002 |
| work_keys_str_mv | AT caronbenedicte covid19andinflammatoryboweldiseasequestionsonincidenceseverityandimpactoftreatment AT arondelyves covid19andinflammatoryboweldiseasequestionsonincidenceseverityandimpactoftreatment AT reimundjeanmarie covid19andinflammatoryboweldiseasequestionsonincidenceseverityandimpactoftreatment |